Decentralized clinical trials platform
Job no longer available
Decentralized clinical trials platform
101-200 employees
Job no longer available
101-200 employees
To bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies.
Desirable
Curebase offers a decentralized clinical trial software which allows research to be carried out at a patient’s home with their own doctor, in an aim to expedite the trial phase of clinical research. While the pandemic itself cast a spotlight on the speed at which we can develop and trial effective medication, it also delayed a whole host of in-person trials for other treatments.
By decentralizing the trial process, Curebase helps patients fit trials into their daily life at home, which has two big payoffs. The first is that trials become faster, and the second is that it diversifies the patients themselves.
They’re not alone in their pursuit to improve clinical trials, with Unlearn.AI and Medable making waves. However, in an industry that's set to be worth $50 billion by 2026, Curebase has made a strong start and is used by the likes of Alira Health, Adaptive Biotechnologies, and Quit Genius.

Freddie
Company Specialist at Welcome to the Jungle
243% employee growth in 12 months
May 2022
$40m
SERIES B
May 2021
$15m
SERIES A
Mission District, San Francisco, CA
Tom Lemberg
(CEO)Studied Computer Science at Harvard, and is a Y Combinator graduate. Interned in Software Development at Amazon, and was a Product Manager at Syapse.
Share this job
